Product Information

ACULAR LS 0.4% OPHTH SOL is a brand product labeled by Allergan, Inc., priced at $54.5502 per ML under NDC 00023927705. Its NADAC has been published 294 times since Mar 19, 2014.

The High Outlier badge above means this manufacturer's average price in the Ketorolac Tromethamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACULAR LS 0.4% OPHTH SOL

Ketorolac Tromethamine
$54.5502per ML
High Outlier

Strength

4 mg/mL

Manufacturer

Allergan, Inc.

NDC

00023927705

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

6/17/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

New Drug (NDA)

FDA Application

NDA021528

On Market Since

8/19/2003

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for ACULAR LS 0.4% OPHTH SOL has been published 294 times since Mar 19, 2014, and over the history we have for it it has risen 56.7%. The table below summarizes its recorded NADAC range and movement.

Current price$54.5502 per ML
All-time high$54.7076 (Jan 14, 2026)
All-time low$34.8212 (Mar 19, 2014)
52-week high$54.7076
52-week low$54.5323
Median price$47.4053
Average price$46.0610
Largest weekly change+9.9% (Jan 13, 2016)
Weeks tracked294
Tracking sinceMar 19, 2014

Price History

1W

0.0%

1M

-0.2%

3M

+0.0%

6M

-0.3%

1Y

+4.8%

3Y

+4.8%

5Y

+4.8%

All

+56.7%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 77%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ACULAR LS 0.4% OPHTH SOL?

The current National Average Drug Acquisition Cost (NADAC) for ACULAR LS 0.4% OPHTH SOL, manufactured by Allergan, Inc., is $54.5502 per ML (NDC 00023927705), effective Jun 24, 2026.

How has the price of ACULAR LS 0.4% OPHTH SOL changed over time?

Over the history we have for it, the NADAC for ACULAR LS 0.4% OPHTH SOL has risen 56.7%. It has been tracked across 294 weekly CMS publications since Mar 19, 2014.

What are the highest and lowest recorded NADAC prices for ACULAR LS 0.4% OPHTH SOL?

Since Mar 19, 2014, the NADAC for ACULAR LS 0.4% OPHTH SOL has ranged from a low of $34.8212 (Mar 19, 2014) to a high of $54.7076 (Jan 14, 2026), with a median of $47.4053 per ML.

Are there cheaper alternatives to ACULAR LS 0.4% OPHTH SOL?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, KETOROLAC 0.4% OPHTH SOLUTION, is $12.8084 per ML — about 77% below ACULAR LS 0.4% OPHTH SOL.

Who manufactures ACULAR LS 0.4% OPHTH SOL?

ACULAR LS 0.4% OPHTH SOL (NDC 00023927705) is labeled by Allergan, Inc., and CMS classifies it as a brand product.